Literature DB >> 17979525

Growth factors and heme oxygenase-1: perspectives in physiology and pathophysiology.

Nathalie Hill-Kapturczak1, Tambi Jarmi, Anupam Agarwal.   

Abstract

Growth factors are mediators of both normal homeostasis and pathophysiology through their effects on various cellular processes. Similarly, heme oxygenase-1 (HO-1) has a role in maintaining physiologic equilibrium, by which it can either alleviate or exacerbate disease, depending on several considerations, including amount, timing, and location of expression, as well as the disease setting. Thus, the synthesis and activities of growth factors and HO-1 are intricately regulated. Interestingly, several growth factors induce HO-1, and, conversely, HO-1 can regulate the expression of some growth factors. This review focuses on the influence of growth factors and HO-1 and potential physiologic effects of the growth factor(s)-HO-1 interaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979525     DOI: 10.1089/ars.2007.1798

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  5 in total

1.  Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure.

Authors:  Richard A Zager; Ali C M Johnson; Kirsten B Frostad
Journal:  Kidney Int       Date:  2016-03-24       Impact factor: 10.612

2.  Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum.

Authors:  Subramaniam Jayanthi; Michael T McCoy; Genevieve Beauvais; Bruce Ladenheim; Kristi Gilmore; William Wood; Kevin Becker; Jean Lud Cadet
Journal:  PLoS One       Date:  2009-06-30       Impact factor: 3.240

3.  Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival.

Authors:  Yong Wei; Xiao-ming Liu; Kelly J Peyton; Hong Wang; Fruzsina K Johnson; Robert A Johnson; William Durante
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-22       Impact factor: 4.249

Review 4.  Heme oxygenase-1 as a target for TGF-β in kidney disease.

Authors:  Abolfazl Zarjou; Anupam Agarwal
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

5.  Biliverdin administration ameliorates cerebral ischemia reperfusion injury in rats and is associated with proinflammatory factor downregulation.

Authors:  Jun-Jie Li; Zhi-Yao Zou; Jia Liu; Liu-Lin Xiong; Hai-Yan Jiang; Ting-Hua Wang; Jian-Lin Shao
Journal:  Exp Ther Med       Date:  2017-06-06       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.